{
    "clinical_study": {
        "@rank": "137961", 
        "arm_group": [
            {
                "arm_group_label": "\"One-per-mil\" Tumescent Solution", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Saline Solution", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to know the characteristic of \"one-per-mil\" tumescent solution in\n      regards of the optimal time delay to achieve optimal visualization of operation field in\n      hand and digit surgery.\n\n      Hypothesis:\n\n        1. Epinephine in \"one-per-mil\" concentration by tumescent injection technique will provide\n           faster decrease in oxygen saturation compared to normal saline solution injected by\n           tumescent technique.\n\n        2. Epinephrine in \"one-per-mil\" concentration by tumescent injection technique will\n           provide effectiveness in vasoconstriction longer than 10 minutes as the optimal time\n           delay.\n\n        3. Epinephine in \"one-per-mil\" concentration by tumescent injection technique causes no\n           finger necrosis as normal saline solution injected by tumescent technique."
        }, 
        "brief_title": "Optimal Time Delay of Epinephrine Injection With \"One-per-mil\" Tumescent Solution", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Ischemia", 
        "condition_browse": {
            "mesh_term": "Ischemia"
        }, 
        "detailed_description": {
            "textblock": "This is a prospective, randomized, double-blind study to measure the optimal time delay of\n      1:1,000,000 epinephrine in saline solution injected by tumescent technique until maximum\n      vasocontriction in the distal finger is achieved.\n\n      Subjects will be injected in both his ring fingers(distal phalanges, volar side) with\n      randomized solutions, one containing \"one-per-mil\" tumescent solution and the other\n      containing only normal saline solution; information which both the injector and examiner are\n      blinded from. Maximum vasoconstriction of the finger injected is depicted by the lowest\n      oxygen saturation (recorded every minute until 45 minutes using pulse oxymeter)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Willing to join the research\n\n          -  BMI 18.5-23\n\n          -  Healthy individual, no history of blood or coagulation disorders\n\n        Exclusion Criteria:\n\n          -  BMI <18.5 or >23\n\n          -  History of blood or coagulation disorder, diabetes mellitus, heavy smoker"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "30 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02033681", 
            "org_study_id": "OPM-1"
        }, 
        "intervention": [
            {
                "arm_group_label": "\"One-per-mil\" Tumescent Solution", 
                "description": "\"One-per-mil\" tumescent solution containing 1:1,000,000 epinephrine concentration in saline solution, is injected to the finger.", 
                "intervention_name": "\"One-per-mil\" Tumescent Solution Injection", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Saline Solution", 
                "description": "Saline solution is injected into the tissue as a placebo control.", 
                "intervention_name": "Saline Solution", 
                "intervention_type": "Procedure"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Epinephrine", 
                "Epinephryl borate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "epinephrine", 
            "hand", 
            "ischemia", 
            "lidocaine", 
            "upper extremity"
        ], 
        "lastchanged_date": "January 9, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Jakarta", 
                    "country": "Indonesia", 
                    "state": "DKI Jakarta", 
                    "zip": "10430"
                }, 
                "name": "Cipto Mangunkusumo Hospital"
            }
        }, 
        "location_countries": {
            "country": "Indonesia"
        }, 
        "number_of_arms": "2", 
        "official_title": "Optimal Time Delay of Epinephrine Injection With \"One-per-mil\" Tumescent Solution to Visualize Operation Field in Hand Surgery Without Tourniquet", 
        "overall_official": {
            "affiliation": "Plastic Surgery Division, Faculty of Medicine University of Indonesia/Cipto Mangunkusumo Hospital", 
            "last_name": "Theddeus OH Prasetyono, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Indonesia: Departement Kesehatan (Department of Health)", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "After being injected with the solution, the ring finger is put on a continuous monitoring of pulse oxymeter, while the examiner records the decrease of oxygen saturation every minute until 45 minutes length of time. The time when lowest oxygen saturation is achieved is recorded, depicting the optimal time delay to achieve maximum vasoconstriction of the finger after injection.", 
            "measure": "Time to achieve lowest oxygen saturation", 
            "safety_issue": "No", 
            "time_frame": "45 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02033681"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Indonesia University", 
            "investigator_full_name": "Theddeus O. H. Prasetyono", 
            "investigator_title": "Research Coordinator of Plastic Surgery Division, Faculty of Medicine, University of Indonesia", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Pain sensation of the finger's pulp was examined (using VAS) and recorded every 15 minutes. These data will be compared to the baseline data prior to injection.", 
                "measure": "Pain Sensation", 
                "safety_issue": "No", 
                "time_frame": "45 minutes"
            }, 
            {
                "description": "Tactile sensation of the finger's pulp was examined (using Semmes Weinstein Touch Test) and recorded every 15 minutes after the injection. We will compare this data with the baseline data collected prior to injection.", 
                "measure": "Tactile Sensation", 
                "safety_issue": "No", 
                "time_frame": "45 minutes"
            }, 
            {
                "description": "Subjects will be observed for 6 hours after the injection to record any sign and symptoms related to the complication of the procedure (persisted pain, pallor, numbness).", 
                "measure": "Complication", 
                "safety_issue": "Yes", 
                "time_frame": "6 hours"
            }, 
            {
                "description": "After injection, temperature of fingertip is measured and recorded every 15 minutes for total time of 45 minutes. The data will be compared with baseline temperature recorded before injection", 
                "measure": "Decrease in fingertip's temperature", 
                "safety_issue": "No", 
                "time_frame": "45 minutes"
            }
        ], 
        "source": "Indonesia University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Indonesia University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}